Laevolac Ameixa

Lactulose, the active ingredient in Laevolac Ameixa, is an osmotic laxative presented as a liquid oral solution for oral use. It is used to treat constipation and to prevent hepatic encephalopathy in patients with liver disease. It works by increasing osmotic pressure in the intestinal lumen, drawing water into the bowel to soften stools and reduce ammonia absorption.

GNH USA supplies Laevolac Ameixa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import.

Laevolac Ameixa (lactulose) is employed in the management of conditions related to bowel motility and hepatic ammonia accumulation.

- Constipation: softens stools and facilitates regular bowel movements. - Hepatic encephalopathy: lowers intestinal ammonia production to help prevent neuropsychiatric episodes. - Recurrent hepatic encephalopathy: maintains low ammonia levels to reduce the frequency of episodes.

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Bloating: sensation of abdominal fullness. - Flatulence: increased intestinal gas. - Abdominal cramps: intermittent stomach pain. - Diarrhoea: loose stools, especially at higher doses. - Nausea: feeling of sickness. - Electrolyte imbalance: mild changes in sodium or potassium levels.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss requiring medical attention. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Hypernatremia: markedly elevated blood sodium. - Hepatic encephalopathy worsening: paradoxical increase in ammonia in rare cases.

Before using Laevolac Ameixa, consider the following safety measures.

- Assess renal function: use with caution in severe renal impairment. - Monitor electrolytes: watch for hyponatremia or potassium shifts. - Avoid in galactosemia: product may contain lactose-derived excipients. - Use caution in diabetic patients: monitor blood glucose as lactulose can affect carbohydrate metabolism. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lactulose can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Broad‑spectrum antibiotics (e.g., neomycin, rifaximin): may reduce colonic bacterial conversion of lactulose, diminishing its effect. - Antacids containing magnesium: can increase the osmotic load and exacerbate diarrhoea.

Moderate Interactions (Monitor Closely): - Diuretics: concurrent use may increase the risk of electrolyte disturbances. - Insulin or oral hypoglycaics: lactulose may affect glucose control; monitor blood sugar levels. - Other laxatives: combined use can lead to excessive bowel movements and dehydration.